Carmat SA (CXT F) stock market data APIs
€0.867
0.01(1.2%)
as of April 23, 2025
Carmat SA Financial Data Overview
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. Its product includes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Prev. Close
0.867
Open
0.8791
High
0.8791
Low
0.867
52 wk Range
0.747-4.31
Market Cap
52 687 K
Shares Outstanding
57 943 K
Revenue
6 926 K
Beta
1.523
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Carmat SA data using free add-ons & libraries
Get Carmat SA Fundamental Data
Carmat SA Fundamental data includes:
- Net Revenue: 6 926 K
- EBITDA: -50 198 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-22
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Carmat SA News
New
CARMAT Achieves a Pivotal Year in 2023 by Reaching the Milestone of 50 Implants of the Aeson® Artificial Heart and Presents Its Development Prospects
50 patients have benefited from CARMAT's Aeson® artificial heart since the first implant in 2013 Aeson® becomes an essential breakthrough innovation in the treatment of advanced biventricular heart ...
CARMAT announces a conditional agreement in principle with the EIB on new loan repayment terms, as part of the management of its short-term financing challenge
The implementation of this agreement would lead to a significant extension of the maturity date of each of three tranches of the loan Extension of the maturity date of the first tranche of the loan (...
CARMAT Announces the Approval of All Resolutions Supported by the Board of Directors at its Extraordinary General Meeting
PARIS, January 05, 2024--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of Aeson®, the world’s most advanced total artificial heart, aiming to provide a the...
CARMAT Announces a Software Enhancement Which Significantly Improves the Safety Profile of Its Aeson® Artificial Heart
In compliance with regulations, the implementation of this modification gives rise to the publication of a "field safety notice". Its roll-out will begin over the next few days. PARIS, December 28, 2...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
